AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 528207: Benzoic acid, 2-hydroxy-3-methoxy, DTBS

Chemical compound data from PubChem database. IUPAC Name: 2,2-ditert-butyl-8-methoxy-1,3,2-benzodioxasilin-4-one. Molecular Formula: C16H24O4Si. Molecular Weight: 308.44. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529946: 2-[2-Methyl-(3-thienyldithio)]pentan-3-one

Chemical compound data from PubChem database. IUPAC Name: 2-[(2-methylthiophen-3-yl)disulfanyl]pentan-3-one. Molecular Formula: C10H14OS3. Molecular Weight: 246.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525580: N,N-Dimethyl-N'-(3-methylphenyl)-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-methoxy-N,N-dimethyl-N'-(3-methylphenyl)benzenecarboximidamide. Molecular Formula: C17H20N2O. Molecular Weight: 268.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526204: 4-Methyl-2-tert-butyl-6-hydroperoxymethyl-phenol

Chemical compound data from PubChem database. IUPAC Name: 2-tert-butyl-6-(hydroperoxymethyl)-4-methylphenol. Molecular Formula: C12H18O3. Molecular Weight: 210.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401243-T1: [Translated] LIGHTING SYSTEM, APPARATUS AND METHOD FOR AIR REFUELING

An illuminating system, device, and method are provided to illuminate an in-flight refueling operation involving a first aircraft, serving as a tanker aircraft and carrying the illuminating system of the present invention, and a second aircraft, entering an in-flight refueling position relative to the first aircraft. The system, device, and method of the present invention provide eye-safe, covert illumination suitable for illuminating the in-flight refueling position such that the second aircraft is illuminated upon entering the in-flight refueling position.
Compound 525656: p-Bromobenzylidene-(3-methoxyphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-(3-methoxyphenyl)methanimine. Molecular Formula: C14H12BrNO. Molecular Weight: 290.15. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528264: Butanedioic acid, methyl phenylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: 4-O-benzyl 1-O-methyl butanedioate. Molecular Formula: C12H14O4. Molecular Weight: 222.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Management of obstetric anal sphincter injury: a systematic review & national practice survey

Background
          We aim to establish the evidence base for the recognition and management of obstetric anal sphincter injury (OASI) and to compare this with current practice amongst UK obstetricians and coloproctologists.
        
        
          Methods
          A systematic review of the literature and a postal questionnaire survey of consultant obstetricians, trainee obstetricians and consultant coloproctologists was carried out.
        
        
          Results
          We found a wide variation in experience of repairing acute anal sphincter injury. The group with largest experience were consultant obstetricians (46.5% undertaking ≥ 5 repairs/year), whilst only 10% of responding colorectal surgeons had similar levels of experience (p < 0.001). There was extensive misunderstanding in terms of the definition of obstetric anal sphincter injuries. Overall, trainees had a greater knowledge of the correct classification (p < 0.01). Observational studies suggest that a new 'overlap' repair using PDS sutures with antibiotic cover gives better functional results. However, our literature search found only one randomised controlled trial (RCT) on the technique of repair of OASI, which showed no difference in incidence of anal incontinence at three months. Despite this, there was a wide variation in practice, with 337(50%) consultants, 82 (55%) trainees and 80 (89%) coloproctologists already using the 'overlap' method for repair of a torn EAS (p < 0.001). Although over 50% of colorectal surgeons would undertake long-term follow-up of their patients, this was the practice of less than 10% of obstetricians (p < 0.001). Whilst over 70% of coloproctologists would recommend an elective caesarean section in a subsequent pregnancy, only 22% of obstetric consultants and 14% of trainees (p < 0.001).
        
        
          Conclusion
          An agreed classification of OASI, development of national guidelines, formalised training, multidisciplinary management and further definitive research is strongly recommended.
Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis

Background
          The potential of ascorbic acid and two botanical decoctions, green tea and cat's claw, to limit cell death in response to oxidants were evaluated in vitro.
        
        
          Methods
          Cultured human gastric epithelial cells (AGS) or murine small intestinal epithelial cells (IEC-18) were exposed to oxidants – DPPH (3 μM), H2O2 (50 μM), peroxynitrite (300 μM) – followed by incubation for 24 hours, with antioxidants (10 μg/ml) administered as a 1 hour pretreatment. Cell number (MTT assay) and death via apoptosis or necrosis (ELISA, LDH release) was determined. The direct interactions between antioxidants and DPPH (100 μM) or H2O2 (50 μM) were evaluated by spectroscopy.
        
        
          Results
          The decoctions did not interact with H2O2, but quenched DPPH although less effectively than vitamin C. In contrast, vitamin C was significantly less effective in protecting human gastric epithelial cells (AGS) from apoptosis induced by DPPH, peroxynitrite and H2O2 (P < 0.001). Green tea and cat's claw were equally protective against peroxynitrite and H2O2, but green tea was more effective than cat's claw in reducing DPPH-induced apoptosis (P < 0.01). Necrotic cell death was marginally evident at these low concentrations of peroxynitrite and H2O2, and was attenuated both by cat's claw and green tea (P < 0.01). In IEC-18 cells, all antioxidants were equally effective as anti-apoptotic agents.
        
        
          Conclusions
          These results indicate that dietary antioxidants can limit epithelial cell death in response to oxidant stress. In the case of green tea and cat's claw, the cytoprotective response exceed their inherent ability to interact with the injurious oxidant, suggestive of actions on intracellular pathways regulating cell death.
Patent AT-E400759-T1: [Translated] VALVE ARRANGEMENT

A valve assembly comprising a chamber, the chamber having an inlet which is adapted to be connected to a source of relatively high pressure fluid, and an outlet which is adapted to be connected to a source of relatively low pressure fluid, and a switch valve which is switchable between a first configuration in which the valve closes the outlet and opens the inlet, and a second configuration in which the valve closes the inlet and opens the outlet, characterised in that a flow control device is provided between the outlet and the volume of relatively low pressure fluid, the flow control device including a restrictor portion which restricts flow of fluid through the flow control device, the extent to which fluid flow is restricted decreasing as the fluid pressure in the chamber increases.
Patent AT-E400191-T1: [Translated] ENRICHED CONFESSIONALS AND METHOD OF PRODUCTION THEREOF

Chewy confectionery products, and processes for producing said products, are provided as delivery systems for minerals such as calcium. The carbohydrates of the fortified confectionery products comprise at least one reducing sugar and one non-reducing sugar in a preferred ratio of about 1:0.2 to about 1:1 reducing sugar:non-reducing sugar. The chewy confectionery products offer a matrix for about 0.2 wt% to 45 wt% of a fortifying component while maintaining a smooth and soft texture.
Compound 528937: Phenol, 2,4-bis-(1,1-dimethylethyl), TMS

Chemical compound data from PubChem database. IUPAC Name: (3,5-ditert-butylphenoxy)-trimethylsilane. Molecular Formula: C17H30OSi. Molecular Weight: 278.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530155: Bufotenin, TMS

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-2-(1-trimethylsilyl-5-trimethylsilyloxyindol-3-yl)ethanamine. Molecular Formula: C18H32N2OSi2. Molecular Weight: 348.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530064: 11-Deoxycortisol, bis(trimethylsilyl) ether, bis(O-methyloxime)

Chemical compound data from PubChem database. IUPAC Name: N-methoxy-17-[N-methoxy-C-(trimethylsilyloxymethyl)carbonimidoyl]-10,13-dimethyl-17-trimethylsilyloxy-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-imine. Molecular Formula: C29H52N2O4Si2. Molecular Weight: 548.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
#DDOD Use Case: Link Open Payments Dataset to National Provider Identifier

<p>SUMMARY</p>
<p>DDOD use case to link Centers for Medicare and Medicaid Services (CMS) Open Payments dataset to a physician's National Provider Identifier (NPI).</p>
<p>WHAT IS A USE CASE?</p>
<p>A “Use Case” is a request that was made by the user community because there were no available datasets that met their particular needs.  If this use case is similar to your needs, we ask that you add your own requirements to the specifications section.</p>
<p>The concept of a use case falls within the <a href="http://hhs.ddod.us ">Demand-Driven Open Data</a> (DDOD) program and gives you a formalized way to identify what data you need.  It’s for anyone in industry, research, media, nonprofits or other government agencies.  Each request becomes a DDOD use case, so that it can be prioritized and worked on.</p>
<p>Use Cases also provide a wealth of insights about existing alternative datasets and tips for interpreting and manipulating data for specific purposes.</p>
<p>PURPOSE</p>
<p>Linking the Open Payments dataset to NPI would allow for matching to other datasets which use NPI.</p>
<p>VALUE</p>
<p>A common physician identifier across all datasets would allow for provider cost and quality analytics across datasets.</p>
<p>USE CASE SPECIFICATIONS &amp; SOLUTION</p>
<p>Information about this use cases is maintained in a wiki: <a href="http://hhs.ddod.us/wiki/Use_Case_29:_Link_Open_Payments_dataset_to_NPI">http://hhs.ddod.us/wiki/Use_Case_29:_Link_Open_Payments_dataset_to_NPI</a></p>
<p>It serves as a knowledge base.</p>
<p>USE CASE DISCUSSION FORUM</p>
<p>All communications between Data Users, DDOD Administrators and Data Owners are logged as discussions within GitHub issues: <a href="https://github.com/demand-driven-open-data/ddod-intake/issues/29">https://github.com/demand-driven-open-data/ddod-intake/issues/29</a></p>
<p>It aims to provide complete transparency into the process and ensure the same message gets to all participants.</p>
<p>CASE STATUS</p>
<p>Closed, as the legislation that made Open Payments possible explicitly forbids reporting of the NPI.</p>
NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection

NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Reporting jurisdictions were informed CDC could receive data for this condition in August 2019. Please note there will be a delay in reporting of case notifications for this condition to CDC.
Compound 526789: 6-Hydroxy-nonadecanoic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 6-[tert-butyl(dimethyl)silyl]oxynonadecanoate. Molecular Formula: C26H54O3Si. Molecular Weight: 442.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529337: 1H-Imidazole, 4-methyl-1-pentyl

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-1-pentylimidazole. Molecular Formula: C9H16N2. Molecular Weight: 152.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP HIV Incidence Rate 2009-2021

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

HIV Incidence Rate  - This indicator shows the rate of adult/adolescent cases (age 13+) diagnosed with HIV (per 100,000 population). HIV is a significant and preventable public health problem. An estimated 16% of people with HIV in Maryland are undiagnosed. We have the knowledge and tools needed to slow the spread of HIV infection and improve the health of people living with HIV. <a href="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/HIV%20Incidence%20Rate.pdf" > Link to Data Details </a>
Youths Living with a Veteran Father Are More Likely to Use Illicit Drugs, Tobacco, or Alcohol (2002 to 2010 NSDUH)

This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month alcohol, cigarette, illicit drug use among youth aged 12 to 17 living with a veteran father and youth living with a nonveteran father.
Hospital Cost Report Audited Data Print Image: 2021

This print image version of the Institutional Cost Report (ICR) has been audited by the DOH. is the Institutional Cost Report (ICR) is a uniform report completed by New York hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. For more information, check out: http://www.health.ny.gov/facilities/hospital/
Compound 527344: 14,18,22,26-Tetramethyl-nonacosyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 15,19,23,27-tetramethyltriacontanenitrile. Molecular Formula: C34H67N. Molecular Weight: 489.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527699: Butanoic acid, 4-chloro, 1-methylbutyl ester

Chemical compound data from PubChem database. IUPAC Name: pentan-2-yl 4-chlorobutanoate. Molecular Formula: C9H17ClO2. Molecular Weight: 192.68. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Healthy Access Locator

Healthy Access Locator map can be used to view schools that have received a Healthier US Schools Challenge Award (HUSSC). To get started, click on Search Awards and enter your search criteria. When the information displays on the map, you can click a star for additional details or see a summary of your results below the map. You can also use the Data Layers feature to display different data layers on obesity and diabetes prevalence, SNAP Participation Rates, and SNAP Outreach Plans by states. (HUSSC Awards as of May 30, 2013).
Dexamethasone 1.5 mg

Dexamethasone 1.5 mg tablets are a prescription corticosteroid medication taken orally. As a corticosteroid hormone receptor agonist, it helps reduce inflammation and suppress the immune system, commonly used for conditions like allergies, arthritis, or certain cancers. Manufactured by Larken Laboratories, Inc. under ANDA201270. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E399975-T1: [Translated] AMMUNITION OR AMMUNITION PART THAT HAS THE SHAPE OF A MISSILE SUCH AS A DRONE

The less energy structure is smoke producing (75%)/lighting (75%) pyrotechnic composition, reinforcement material (15%), brass/brass powder (15%) and aluminized carbon/glass (25%). The fibers (0-5%) are kevlar, hemp, glass and carbon fibers (20%). The masking/deception materials (0-5%) are short carbon fibers, carbon and brass powders, bronze, spangles, metallized and covered polymeric fibers, conducting material and red phosphorus. The energetic material is covered by a protection layer. The reinforcement materials (10-30%) are micro balloons (10%), phenolics, polystyrene, trinitrotoluene (20%), hexogen (50%) and nanocarbon tubes. The energetic components are fusible secondary explosive material (10-30%) associated with a nonfusible explosive (50-60%) and synthetic binder (10-30%). The energetic material is useful for forming a body and/or wings of a pilotless aircraft. The load material is useful for camera and/or relay of information transmission of the pilotless aircraft.
Compound 530735: m-Anisic acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl 3-methoxybenzoate. Molecular Formula: C17H22O3. Molecular Weight: 274.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400439-T1: [Translated] INKJET RECORDING METHOD AND METHOD FOR REDUCING GLOSS DIFFERENCE IN AN INKJET IMAGE

The invention relates to a process for producing a high-quality ink-jet recorded image. The process comprises the steps of (i) applying a first ink containing at least one colorant to an opaque printing medium by an ink-jet method to form a visible image; and (ii) applying a second ink, which does not change or substantially not change the hue of the printing medium, to a portion of the printing medium that is complementary to the visible image, thereby alleviating a difference in gloss between the visible image and the portion complementary to the visible image. <IMAGE>
Patent AT-E399907-T1: [Translated] CURTAIN FACADE

It is structured in the form of a bearing sheet made up of a series of profiled plates (1), which run from the ground to the roof, grooved, to form trays with a U-shaped section, which are attached by their central branch to the front edge of the floor slabs and whose side branches (2) serve as supports and spacers for an exterior sheet (7), which forms the exposed face of the front wall, using modular pieces (9) that are mounted on strips (10) suitably attached to the front edge (3) of the trays (1), or panels that are directly secured to those edges if there are no strips. The respective layers (6) of insulation and soundproofing material lie at the bottom of the trays (1), which are still at a considerable distance from the exterior sheet (7), forming a ventilated chamber that also runs from the floor to the roof, while the internal face of the bearing sheet (5) adapts to the insertion of another insulating and soundproofing layer (13), an inner sheet (12), which takes the form of a self-supporting back made up of panels composed of plaster sheets on a galvanised steel structure.
Olanzapine

Olanzapine is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. This generic version comes as orally disintegrating tablets in 5 mg, 10 mg, 15 mg, and 20 mg strengths, manufactured by Lannett Company, Inc. under application ANDA208146. This information was generated using AI and is provided for informational and research purposes only.
Comparison of 2010-2011 and 2011-2012 NSDUH State Prevalence Estimates

This report presents trends of estimates for measures of substance use and mental health based on the combined 2010 and 2011 and the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.